Locations
Montreal, QC, Canada
industry
Biotechnology · DeepTech
Size
11-50 employees
Stage
Seed
founded in
2023
Ability Biologics is a leading biotherapeutic targeting company focused on developing innovative, immune-modulating biotherapeutics to address unmet medical needs in cancer and autoimmune diseases. Utilizing their proprietary Abi Leap™ discovery engine, they produce fully human, Ig G-based multispecific antibodies with exceptional selectivity and affinity. Their technology leverages artificial intelligence and a vast database of antigen-antibody interactions to create highly specific therapeutics. The company is dedicated to advancing preclinical antibody candidates and aims to conduct human proof of concept clinical trials, positioning itself as a key player in the biotherapeutics market.
Something looks off?